Total Funding
36
9
Total FundingVenture - Series Unknown raised
Growth Score
-1 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1253257
Efranat was established in 2009 by, Prof. Nobuto Yamamoto, Boaz Shoam and Avi Levin.
Avi Levin: Founder
Boaz Shoham: Founder
About the Company
Efranat Ltd. was established in 2009 by, Prof. Nobuto Yamamoto, Boaz Shoam and Avi Levin. The Company was named after Avi and Boaz's wives, Efrat and Anat who died of cancer in 2009.
A year before, during their quest to find a cure for their wives’ illness, Avi and Boaz met with Prof. Yamamoto, a world known researcher in the field of
Cancer Immunotherapy. Prof. Yamamoto life's work was the discovery of a glycoprotein which he named "GcMAF" (Globulin component Macrophage Activating Factor) a molecule that activates Macrophages,to act against cancer cells.
